Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients.
Dolcetti E, Buttari F, Bruno A, Azzolini F, Gilio L, Di Caprio V, Lauritano G, Borrelli A, Galifi G, Furlan R, Finardi A, Musella A, Guadalupi L, Mandolesi G, Rovella V, Centonze D, Stampanoni Bassi M. Dolcetti E, et al. Among authors: borrelli a. Front Neurol. 2024 Feb 23;15:1326506. doi: 10.3389/fneur.2024.1326506. eCollection 2024. Front Neurol. 2024. PMID: 38585351 Free PMC article.
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis.
Bruno A, Buttari F, Dolcetti E, Azzolini F, Borrelli A, Lauritano G, Di Caprio V, Rizzo FR, Gilio L, Galifi G, Furlan R, Finardi A, Guadalupi L, Musella A, Mandolesi G, Centonze D, Stampanoni Bassi M. Bruno A, et al. Among authors: borrelli a. Mult Scler. 2023 Oct;29(11-12):1383-1392. doi: 10.1177/13524585231197928. Epub 2023 Sep 12. Mult Scler. 2023. PMID: 37698019
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis.
Stampanoni Bassi M, Gilio L, Buttari F, Dolcetti E, Bruno A, Galifi G, Azzolini F, Borrelli A, Mandolesi G, Gentile A, De Vito F, Musella A, Simonelli I, Centonze D, Iezzi E. Stampanoni Bassi M, et al. Among authors: borrelli a. Eur J Neurol. 2024 Mar;31(3):e16071. doi: 10.1111/ene.16071. Epub 2023 Sep 27. Eur J Neurol. 2024. PMID: 37754770 Free PMC article.
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis.
Sanna K, Bruno A, Balletta S, Caioli S, Nencini M, Fresegna D, Guadalupi L, Dolcetti E, Azzolini F, Buttari F, Fantozzi R, Borrelli A, Stampanoni Bassi M, Gilio L, Lauritano G, Vanni V, De Vito F, Tartacca A, Mariani F, Rovella V, Musella A, Centonze D, Mandolesi G. Sanna K, et al. Among authors: borrelli a. Front Immunol. 2024 Jun 7;15:1416133. doi: 10.3389/fimmu.2024.1416133. eCollection 2024. Front Immunol. 2024. PMID: 38911847 Free PMC article.
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis.
Gilio L, Fresegna D, Stampanoni Bassi M, Musella A, De Vito F, Balletta S, Sanna K, Caioli S, Pavone L, Galifi G, Simonelli I, Guadalupi L, Vanni V, Buttari F, Dolcetti E, Bruno A, Azzolini F, Borrelli A, Fantozzi R, Finardi A, Furlan R, Centonze D, Mandolesi G. Gilio L, et al. Among authors: borrelli a. Front Mol Neurosci. 2024 Aug 7;17:1430080. doi: 10.3389/fnmol.2024.1430080. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39169949 Free PMC article.
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression.
Femiano C, Bruno A, Gilio L, Buttari F, Dolcetti E, Galifi G, Azzolini F, Borrelli A, Furlan R, Finardi A, Musella A, Mandolesi G, Storto M, Centonze D, Stampanoni Bassi M. Femiano C, et al. Among authors: borrelli a. Sci Rep. 2024 Aug 27;14(1):19796. doi: 10.1038/s41598-024-67165-9. Sci Rep. 2024. PMID: 39187524 Free PMC article.
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis.
Dolcetti E, Buttari F, Bruno A, Azzolini F, Gilio L, Borrelli A, Di Caprio V, Lauritano G, Galifi G, Gambardella S, Ferese R, Giardina E, Rovella V, Furlan R, Finardi A, Musella A, Balletta S, Mandolesi G, Centonze D, Stampanoni Bassi M. Dolcetti E, et al. Among authors: borrelli a. Int J Mol Sci. 2024 Aug 22;25(16):9108. doi: 10.3390/ijms25169108. Int J Mol Sci. 2024. PMID: 39201794 Free PMC article.
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).
Gentile I, Giaccone A, Scirocco MM, Di Brizzi F, Cuccurullo F, Silvitelli M, Ametrano L, Alfè FA, Pietroluongo D, Irace I, Chiariello M, De Felice N, Severino S, Viceconte G, Schiano Moriello N, Maraolo AE, Buonomo AR, Scotto R; Federico II COVID team. Gentile I, et al. BMC Infect Dis. 2024 Dec 18;24(1):1434. doi: 10.1186/s12879-024-10303-5. BMC Infect Dis. 2024. PMID: 39696011 Free PMC article.
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators.
Tomati V, Capurro V, Pesce E, Pastorino C, Sondo E, Lena M, Borrelli A, Cresta F, Pantano S, Collini F, Ripani P, Terlizzi V, Fevola C, Costa S, Lucanto MC, Zara F, Bandiera T, Bocciardi R, Castellani C, Galietta LJV, Pedemonte N. Tomati V, et al. Among authors: borrelli a. Front Pharmacol. 2024 Nov 18;15:1494327. doi: 10.3389/fphar.2024.1494327. eCollection 2024. Front Pharmacol. 2024. PMID: 39624835 Free PMC article.
337 results